Several thousand people in the United States work full-time on mosquito control. Only a few dozen work on public-health tick control Emerging Infectious Diseases (CDC), 2020. That single fact explains more about why tick-borne diseases are winning than any number of studies on acaricide efficacy or vaccine pipelines.
The Structural Gap
The framing originates with Piesman and Eisen in a 2008 review of tick-borne disease prevention:
"Mosquito control is a community responsibility; tick control is an individual homeowner responsibility. This may explain why currently in the United States, several thousand people are dedicated to mosquito control, whereas only a few dozen are dedicated to public-health related tick control." Annual Review of Entomology / CDC, 2008, as cited in Journal of Medical Entomology / PMC, 2021
That observation was made when the problem was simpler. In the 1990s, tick control as an individual homeowner responsibility made sense: Lyme disease was the primary concern, most infections occurred in the northeastern United States, and residential properties were the most common location for tick encounters Emerging Infectious Diseases (CDC), 2020. The threat was one tick species, one disease, one region, one setting.
That scenario no longer exists. Three major tick species in the eastern US — Ixodes scapularis, Amblyomma americanum, and Dermacentor variabilis — now collectively transmit at least 14 human pathogens Journal of Medical Entomology / PMC, 2021. The CDC estimates more than 476,000 new cases of Lyme disease are diagnosed each year U.S. Department of Health and Human Services, 2022, and tick-borne diseases represent more than 75% of all reported vector-borne infections in the country U.S. Department of Health and Human Services, 2022.
"The strategies devised 2 decades ago to address I. scapularis ticks and Lyme disease spirochetes on residential properties in the Northeast are not necessarily well suited to address the current broader, more complex, and spatially diffuse threat of ticks and tickborne diseases in the United States." Emerging Infectious Diseases (CDC), 2020
What the Individual-Responsibility Model Actually Produces
When tick control is the homeowner's problem, most homeowners do nothing. Over half of respondents (51.2%) in national HealthStyles surveys reported not routinely taking personal prevention steps against tick bites, and even fewer (10.7%) used yard pesticides to control ticks Oxford University Press (Journal of Integrated Pest Management), 2017. Use of tick repellents runs at only 20–40% even in highly endemic New England and Mid-Atlantic states Journal of Medical Entomology / PMC, 2021.
Cost is a fundamental barrier. The typical charge from pest control companies for a single tick treatment is $150–200 per acre, but the majority of homeowners are unwilling to spend more than $100 per year on tick control Journal of Medical Entomology / PMC, 2021. In Connecticut — one of the highest-incidence Lyme states — 19% of homeowners were unwilling to spend any money at all on tick control Oxford University Press (Journal of Integrated Pest Management), 2017.
Even when homeowners do pay for treatment, the results are uncertain. A research study evaluating a single annual barrier spray of synthetic acaricide on residential properties showed 45–69% suppression of host-seeking I. scapularis nymphs within treated habitat — but no reduction in human tick encounters for residents Journal of Medical Entomology / PMC, 2021.
"An IPM approach for tick control does not easily fit a pest control model within existing pest control company business practices and what clients are willing to pay for tick control services." Journal of Medical Entomology / PMC, 2021, citing Jordan and Schulze 2019
Why the Market Can't Solve This
The private sector has little incentive to invest. The Tick-Borne Disease Working Group's final report to Congress identified the core problem:
"Several subcommittees cited increased government intervention in the development of diagnostics and treatment protocols as detrimental to transforming the tick-borne disease landscape. The subcommittee members believed that progress has been impeded by a heavy regulatory burden and low likelihood of profitability, which discourage the private-sector investments needed to catalyze the entry of new products into the market." U.S. Department of Health and Human Services, 2022
The timeline for new products illustrates the problem. Nootkatone, a tick-killing compound derived from Alaskan yellow cedar, took nearly 15 years from initial proof-of-concept to near product registration Journal of Medical Entomology / PMC, 2021. The first human Lyme disease vaccine was pulled from the market in 2002, and nearly two decades later only one candidate (VLA15) has progressed to Phase 2 clinical trials Journal of Medical Entomology / PMC, 2021. Meanwhile, 80% of pest control companies in the NJ/NY/PA area still rely primarily on bifenthrin — and the majority were unfamiliar with entomopathogenic fungal products or newer rodent-targeted bait box systems Journal of Medical Entomology / PMC, 2021.
The combined national response, as HHS concluded in its most comprehensive assessment, "remains inadequate" U.S. Department of Health and Human Services, 2022:
"Prevention products and diagnostic technologies are badly needed, yet there is no clear path to bring them to market, and little has been done to remove existing barriers." U.S. Department of Health and Human Services, 2022
What Would Have to Change
The answer, according to CDC researchers, is structural:
"The negative societal effects of ticks and tickborne diseases in the United States, including a general feeling that family members are not safe during outdoor activities in the backyard and elsewhere, has reached the point where we need to rethink the basic concepts of how to counter this threat." Emerging Infectious Diseases (CDC), 2020
The proposed shift is two-pronged: individual homeowners remain responsible for their own properties and personal protection, while professionally staffed local programs take responsibility for public outreach, assistance to homeowners, and control of ticks in high-use public areas like neighborhood green spaces, hiking trails, and picnic areas Emerging Infectious Diseases (CDC), 2020. Expanding existing mosquito management programs to include ticks would provide an economy of scale — shared laboratory space, experienced pesticide applicators, and public outreach personnel already skilled in vector-related issues Emerging Infectious Diseases (CDC), 2020.
No single method will be sufficient. As Stafford and colleagues concluded from decades of research:
"It is increasingly apparent that under most circumstances, no one method is likely to be universally acceptable to homeowners or provide sufficient suppression of tick abundance or the prevalence of the pathogen in the vector or reservoir host in order to prevent human disease." Oxford University Press (Journal of Integrated Pest Management), 2017
The tools exist. The organizational infrastructure to deploy them does not. That is the policy failure.